Dermata Therapeutics (DRMAW) Stock Chart & Stock Price History $0.02 +0.00 (+15.50%) As of 08/8/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 10.20%, with a year-to-date return of 76.64%. In the past month, the stock has decreased 5.50%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.02 with a market cap of and volume of 250 shares. Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-17.83%1 Month Performance-5.50%3 Month Performance-24.10%Year-To-Date Performance+76.64%1 Year Performance+10.20% DRMAW Stock Chart for Sunday, August, 10, 2025 DRMAW Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.02$0.02-18.18%$0.02$0.02250 shs$0.0008/07/2025$0.02$0.02+0.43%$0.02$0.028,500 shs$0.0008/06/2025$0.02$0.02$0.02$0.028,500 shs$0.0008/05/2025$0.02$0.02+1.32%$0.02$0.028,500 shs$0.0008/04/2025$0.02$0.02+43.67%$0.02$0.028,500 shs$0.0008/01/2025$0.02$0.02-16.40%$0.02$0.028,595 shs$0.0007/31/2025$0.02$0.02-3.57%$0.02$0.0219,613 shs$0.0007/30/2025$0.02$0.02+18.07%$0.02$0.0210,223 shs$0.0007/29/2025$0.02$0.02-16.58%$0.02$0.0210,223 shs$0.0007/28/2025$0.02$0.02+9.34%$0.02$0.0210,223 shs$0.00 Get the Latest News and Ratings for DRMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$0.02$0.02+15.92%$0.02$0.02100 shs$0.0007/24/2025$0.02$0.02$0.02$0.02600 shs$0.0007/23/2025$0.02$0.02-0.63%$0.02$0.02659 shs$0.0007/22/2025$0.02$0.02-11.24%$0.02$0.02350 shs$0.0007/21/2025$0.02$0.02$0.02$0.021,200 shs$0.0007/18/2025$0.02$0.02-0.01%$0.02$0.021,250 shs$0.0007/17/2025$0.02$0.02+5.33%$0.02$0.02100 shs$0.0007/16/2025$0.02$0.02$0.02$0.02100 shs$0.0007/15/2025$0.02$0.02$0.02$0.02100 shs$0.0007/14/2025$0.02$0.02$0.02$0.021,000 shs$0.0007/11/2025$0.02$0.02-15.50%$0.02$0.021,000 shs$0.0007/10/2025$0.02$0.02$0.02$0.021,000 shs$0.0007/09/2025$0.02$0.02+13.64%$0.02$0.021,012 shs$0.00 Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ARAV Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMAW) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRMAW Stock Alerts